Citius Oncology, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Leonard L. Mazur, with a market cap of $58.3M.
Common questions about Citius Oncology, Inc.
Citius Oncology, Inc. is scheduled to report earnings for Q2 2026 on May 13, 2026. Analysts estimate revenue of $7.0M.
We use cookies for analytics. See our Privacy and Cookie Policy.